nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—ulcerative colitis	0.568	1	CbGaD
Terazosin—ABCB1—Methylprednisolone—ulcerative colitis	0.0324	0.257	CbGbCtD
Terazosin—ABCB1—Betamethasone—ulcerative colitis	0.021	0.167	CbGbCtD
Terazosin—ABCB1—Prednisolone—ulcerative colitis	0.0208	0.165	CbGbCtD
Terazosin—ABCB1—Hydrocortisone—ulcerative colitis	0.0197	0.157	CbGbCtD
Terazosin—ABCB1—Prednisone—ulcerative colitis	0.0196	0.156	CbGbCtD
Terazosin—ABCB1—Dexamethasone—ulcerative colitis	0.0122	0.0974	CbGbCtD
Terazosin—Doxazosin—ABCB1—ulcerative colitis	0.000992	0.52	CrCbGaD
Terazosin—Prazosin—ABCB1—ulcerative colitis	0.000914	0.479	CrCbGaD
Terazosin—Diarrhoea—Azathioprine—ulcerative colitis	0.000315	0.00112	CcSEcCtD
Terazosin—Discomfort—Prednisolone—ulcerative colitis	0.000315	0.00112	CcSEcCtD
Terazosin—Angioedema—Triamcinolone—ulcerative colitis	0.000315	0.00112	CcSEcCtD
Terazosin—Angioedema—Methylprednisolone—ulcerative colitis	0.000314	0.00112	CcSEcCtD
Terazosin—Myalgia—Hydrocortisone—ulcerative colitis	0.000311	0.00111	CcSEcCtD
Terazosin—Malaise—Triamcinolone—ulcerative colitis	0.00031	0.00111	CcSEcCtD
Terazosin—Anxiety—Hydrocortisone—ulcerative colitis	0.00031	0.0011	CcSEcCtD
Terazosin—Malaise—Methylprednisolone—ulcerative colitis	0.00031	0.0011	CcSEcCtD
Terazosin—Vertigo—Triamcinolone—ulcerative colitis	0.000309	0.0011	CcSEcCtD
Terazosin—Hypersensitivity—Mesalazine—ulcerative colitis	0.000309	0.0011	CcSEcCtD
Terazosin—Syncope—Triamcinolone—ulcerative colitis	0.000309	0.0011	CcSEcCtD
Terazosin—Vertigo—Methylprednisolone—ulcerative colitis	0.000309	0.0011	CcSEcCtD
Terazosin—Syncope—Methylprednisolone—ulcerative colitis	0.000308	0.0011	CcSEcCtD
Terazosin—Discomfort—Hydrocortisone—ulcerative colitis	0.000308	0.0011	CcSEcCtD
Terazosin—Nausea—Budesonide—ulcerative colitis	0.000306	0.00109	CcSEcCtD
Terazosin—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000305	0.00109	CcSEcCtD
Terazosin—Oedema—Prednisolone—ulcerative colitis	0.000305	0.00109	CcSEcCtD
Terazosin—Dizziness—Azathioprine—ulcerative colitis	0.000305	0.00108	CcSEcCtD
Terazosin—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000303	0.00108	CcSEcCtD
Terazosin—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000302	0.00108	CcSEcCtD
Terazosin—Asthenia—Mesalazine—ulcerative colitis	0.000301	0.00107	CcSEcCtD
Terazosin—Shock—Prednisolone—ulcerative colitis	0.000301	0.00107	CcSEcCtD
Terazosin—Cough—Triamcinolone—ulcerative colitis	0.0003	0.00107	CcSEcCtD
Terazosin—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000298	0.00106	CcSEcCtD
Terazosin—Oedema—Hydrocortisone—ulcerative colitis	0.000298	0.00106	CcSEcCtD
Terazosin—Convulsion—Triamcinolone—ulcerative colitis	0.000298	0.00106	CcSEcCtD
Terazosin—Tachycardia—Prednisolone—ulcerative colitis	0.000298	0.00106	CcSEcCtD
Terazosin—Convulsion—Methylprednisolone—ulcerative colitis	0.000298	0.00106	CcSEcCtD
Terazosin—Pruritus—Mesalazine—ulcerative colitis	0.000297	0.00106	CcSEcCtD
Terazosin—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000295	0.00105	CcSEcCtD
Terazosin—Shock—Hydrocortisone—ulcerative colitis	0.000294	0.00105	CcSEcCtD
Terazosin—Myalgia—Triamcinolone—ulcerative colitis	0.000293	0.00104	CcSEcCtD
Terazosin—Vomiting—Azathioprine—ulcerative colitis	0.000293	0.00104	CcSEcCtD
Terazosin—Myalgia—Methylprednisolone—ulcerative colitis	0.000292	0.00104	CcSEcCtD
Terazosin—Arthralgia—Methylprednisolone—ulcerative colitis	0.000292	0.00104	CcSEcCtD
Terazosin—Eye disorder—Prednisone—ulcerative colitis	0.000292	0.00104	CcSEcCtD
Terazosin—Anxiety—Methylprednisolone—ulcerative colitis	0.000291	0.00104	CcSEcCtD
Terazosin—Tachycardia—Hydrocortisone—ulcerative colitis	0.000291	0.00104	CcSEcCtD
Terazosin—Rash—Azathioprine—ulcerative colitis	0.00029	0.00103	CcSEcCtD
Terazosin—Dermatitis—Azathioprine—ulcerative colitis	0.00029	0.00103	CcSEcCtD
Terazosin—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.00029	0.00103	CcSEcCtD
Terazosin—Ill-defined disorder—Betamethasone—ulcerative colitis	0.00029	0.00103	CcSEcCtD
Terazosin—Discomfort—Triamcinolone—ulcerative colitis	0.00029	0.00103	CcSEcCtD
Terazosin—Discomfort—Methylprednisolone—ulcerative colitis	0.000289	0.00103	CcSEcCtD
Terazosin—Headache—Azathioprine—ulcerative colitis	0.000289	0.00103	CcSEcCtD
Terazosin—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000288	0.00103	CcSEcCtD
Terazosin—Diarrhoea—Mesalazine—ulcerative colitis	0.000287	0.00102	CcSEcCtD
Terazosin—Dry mouth—Triamcinolone—ulcerative colitis	0.000287	0.00102	CcSEcCtD
Terazosin—Angioedema—Betamethasone—ulcerative colitis	0.000285	0.00102	CcSEcCtD
Terazosin—Angioedema—Dexamethasone—ulcerative colitis	0.000285	0.00102	CcSEcCtD
Terazosin—Anorexia—Hydrocortisone—ulcerative colitis	0.000284	0.00101	CcSEcCtD
Terazosin—Confusional state—Methylprednisolone—ulcerative colitis	0.000283	0.00101	CcSEcCtD
Terazosin—Malaise—Dexamethasone—ulcerative colitis	0.000282	0.001	CcSEcCtD
Terazosin—Malaise—Betamethasone—ulcerative colitis	0.000282	0.001	CcSEcCtD
Terazosin—Oedema—Triamcinolone—ulcerative colitis	0.000281	0.001	CcSEcCtD
Terazosin—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000281	0.001	CcSEcCtD
Terazosin—Vertigo—Betamethasone—ulcerative colitis	0.000281	0.001	CcSEcCtD
Terazosin—Vertigo—Dexamethasone—ulcerative colitis	0.000281	0.001	CcSEcCtD
Terazosin—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.00028	0.000998	CcSEcCtD
Terazosin—Syncope—Dexamethasone—ulcerative colitis	0.00028	0.000998	CcSEcCtD
Terazosin—Syncope—Betamethasone—ulcerative colitis	0.00028	0.000998	CcSEcCtD
Terazosin—Arrhythmia—Prednisone—ulcerative colitis	0.000279	0.000994	CcSEcCtD
Terazosin—Hypotension—Hydrocortisone—ulcerative colitis	0.000279	0.000993	CcSEcCtD
Terazosin—Dizziness—Mesalazine—ulcerative colitis	0.000277	0.000988	CcSEcCtD
Terazosin—Shock—Triamcinolone—ulcerative colitis	0.000276	0.000984	CcSEcCtD
Terazosin—Insomnia—Prednisolone—ulcerative colitis	0.000276	0.000984	CcSEcCtD
Terazosin—Shock—Methylprednisolone—ulcerative colitis	0.000276	0.000982	CcSEcCtD
Terazosin—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000275	0.000978	CcSEcCtD
Terazosin—Loss of consciousness—Betamethasone—ulcerative colitis	0.000275	0.000978	CcSEcCtD
Terazosin—Paraesthesia—Prednisolone—ulcerative colitis	0.000274	0.000977	CcSEcCtD
Terazosin—Tachycardia—Triamcinolone—ulcerative colitis	0.000274	0.000977	CcSEcCtD
Terazosin—Nausea—Azathioprine—ulcerative colitis	0.000274	0.000975	CcSEcCtD
Terazosin—Tachycardia—Methylprednisolone—ulcerative colitis	0.000274	0.000974	CcSEcCtD
Terazosin—Malnutrition—Prednisone—ulcerative colitis	0.000272	0.000969	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000272	0.000968	CcSEcCtD
Terazosin—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000272	0.000967	CcSEcCtD
Terazosin—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000271	0.000965	CcSEcCtD
Terazosin—Convulsion—Dexamethasone—ulcerative colitis	0.000271	0.000964	CcSEcCtD
Terazosin—Convulsion—Betamethasone—ulcerative colitis	0.000271	0.000964	CcSEcCtD
Terazosin—Insomnia—Hydrocortisone—ulcerative colitis	0.00027	0.000961	CcSEcCtD
Terazosin—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000268	0.000954	CcSEcCtD
Terazosin—Vomiting—Mesalazine—ulcerative colitis	0.000267	0.00095	CcSEcCtD
Terazosin—Myalgia—Betamethasone—ulcerative colitis	0.000266	0.000947	CcSEcCtD
Terazosin—Myalgia—Dexamethasone—ulcerative colitis	0.000266	0.000947	CcSEcCtD
Terazosin—Anxiety—Betamethasone—ulcerative colitis	0.000265	0.000944	CcSEcCtD
Terazosin—Anxiety—Dexamethasone—ulcerative colitis	0.000265	0.000944	CcSEcCtD
Terazosin—Rash—Mesalazine—ulcerative colitis	0.000265	0.000942	CcSEcCtD
Terazosin—Dermatitis—Mesalazine—ulcerative colitis	0.000264	0.000941	CcSEcCtD
Terazosin—Headache—Mesalazine—ulcerative colitis	0.000263	0.000936	CcSEcCtD
Terazosin—Discomfort—Dexamethasone—ulcerative colitis	0.000263	0.000936	CcSEcCtD
Terazosin—Discomfort—Betamethasone—ulcerative colitis	0.000263	0.000936	CcSEcCtD
Terazosin—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000263	0.000935	CcSEcCtD
Terazosin—Hypotension—Methylprednisolone—ulcerative colitis	0.000262	0.000933	CcSEcCtD
Terazosin—Pain—Prednisolone—ulcerative colitis	0.000261	0.000931	CcSEcCtD
Terazosin—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000259	0.000924	CcSEcCtD
Terazosin—Fatigue—Hydrocortisone—ulcerative colitis	0.000257	0.000916	CcSEcCtD
Terazosin—Vision blurred—Prednisone—ulcerative colitis	0.000256	0.000913	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000256	0.000912	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000255	0.00091	CcSEcCtD
Terazosin—Pain—Hydrocortisone—ulcerative colitis	0.000255	0.000909	CcSEcCtD
Terazosin—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000255	0.000908	CcSEcCtD
Terazosin—Oedema—Betamethasone—ulcerative colitis	0.000255	0.000908	CcSEcCtD
Terazosin—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000255	0.000908	CcSEcCtD
Terazosin—Oedema—Dexamethasone—ulcerative colitis	0.000255	0.000908	CcSEcCtD
Terazosin—Insomnia—Triamcinolone—ulcerative colitis	0.000254	0.000905	CcSEcCtD
Terazosin—Insomnia—Methylprednisolone—ulcerative colitis	0.000254	0.000903	CcSEcCtD
Terazosin—Ill-defined disorder—Prednisone—ulcerative colitis	0.000252	0.000899	CcSEcCtD
Terazosin—Paraesthesia—Triamcinolone—ulcerative colitis	0.000252	0.000899	CcSEcCtD
Terazosin—Feeling abnormal—Prednisolone—ulcerative colitis	0.000252	0.000897	CcSEcCtD
Terazosin—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000252	0.000897	CcSEcCtD
Terazosin—Shock—Dexamethasone—ulcerative colitis	0.000251	0.000893	CcSEcCtD
Terazosin—Shock—Betamethasone—ulcerative colitis	0.000251	0.000893	CcSEcCtD
Terazosin—Dyspnoea—Triamcinolone—ulcerative colitis	0.00025	0.000892	CcSEcCtD
Terazosin—Thrombocytopenia—Betamethasone—ulcerative colitis	0.00025	0.000889	CcSEcCtD
Terazosin—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.00025	0.000889	CcSEcCtD
Terazosin—Nausea—Mesalazine—ulcerative colitis	0.000249	0.000888	CcSEcCtD
Terazosin—Tachycardia—Betamethasone—ulcerative colitis	0.000249	0.000886	CcSEcCtD
Terazosin—Tachycardia—Dexamethasone—ulcerative colitis	0.000249	0.000886	CcSEcCtD
Terazosin—Angioedema—Prednisone—ulcerative colitis	0.000249	0.000885	CcSEcCtD
Terazosin—Dyspepsia—Triamcinolone—ulcerative colitis	0.000247	0.000881	CcSEcCtD
Terazosin—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000247	0.000879	CcSEcCtD
Terazosin—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000246	0.000878	CcSEcCtD
Terazosin—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000246	0.000878	CcSEcCtD
Terazosin—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000246	0.000876	CcSEcCtD
Terazosin—Malaise—Prednisone—ulcerative colitis	0.000245	0.000874	CcSEcCtD
Terazosin—Vertigo—Prednisone—ulcerative colitis	0.000244	0.00087	CcSEcCtD
Terazosin—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000244	0.000869	CcSEcCtD
Terazosin—Syncope—Prednisone—ulcerative colitis	0.000244	0.000869	CcSEcCtD
Terazosin—Anorexia—Dexamethasone—ulcerative colitis	0.000243	0.000865	CcSEcCtD
Terazosin—Anorexia—Betamethasone—ulcerative colitis	0.000243	0.000865	CcSEcCtD
Terazosin—Fatigue—Triamcinolone—ulcerative colitis	0.000242	0.000863	CcSEcCtD
Terazosin—Fatigue—Methylprednisolone—ulcerative colitis	0.000242	0.000861	CcSEcCtD
Terazosin—Pain—Triamcinolone—ulcerative colitis	0.00024	0.000856	CcSEcCtD
Terazosin—Loss of consciousness—Prednisone—ulcerative colitis	0.000239	0.000852	CcSEcCtD
Terazosin—Hypotension—Dexamethasone—ulcerative colitis	0.000238	0.000848	CcSEcCtD
Terazosin—Hypotension—Betamethasone—ulcerative colitis	0.000238	0.000848	CcSEcCtD
Terazosin—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000236	0.00084	CcSEcCtD
Terazosin—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000236	0.00084	CcSEcCtD
Terazosin—Convulsion—Prednisone—ulcerative colitis	0.000236	0.000839	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000232	0.000827	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000232	0.000827	CcSEcCtD
Terazosin—Arthralgia—Prednisone—ulcerative colitis	0.000232	0.000825	CcSEcCtD
Terazosin—Myalgia—Prednisone—ulcerative colitis	0.000232	0.000825	CcSEcCtD
Terazosin—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000232	0.000825	CcSEcCtD
Terazosin—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000231	0.000823	CcSEcCtD
Terazosin—Anxiety—Prednisone—ulcerative colitis	0.000231	0.000822	CcSEcCtD
Terazosin—Insomnia—Betamethasone—ulcerative colitis	0.000231	0.000821	CcSEcCtD
Terazosin—Insomnia—Dexamethasone—ulcerative colitis	0.000231	0.000821	CcSEcCtD
Terazosin—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000229	0.000816	CcSEcCtD
Terazosin—Paraesthesia—Betamethasone—ulcerative colitis	0.000229	0.000815	CcSEcCtD
Terazosin—Paraesthesia—Dexamethasone—ulcerative colitis	0.000229	0.000815	CcSEcCtD
Terazosin—Discomfort—Prednisone—ulcerative colitis	0.000229	0.000815	CcSEcCtD
Terazosin—Hypersensitivity—Prednisolone—ulcerative colitis	0.000225	0.000802	CcSEcCtD
Terazosin—Dyspepsia—Dexamethasone—ulcerative colitis	0.000224	0.000799	CcSEcCtD
Terazosin—Dyspepsia—Betamethasone—ulcerative colitis	0.000224	0.000799	CcSEcCtD
Terazosin—Body temperature increased—Triamcinolone—ulcerative colitis	0.000222	0.000791	CcSEcCtD
Terazosin—Oedema—Prednisone—ulcerative colitis	0.000222	0.000791	CcSEcCtD
Terazosin—Anaphylactic shock—Prednisone—ulcerative colitis	0.000222	0.000791	CcSEcCtD
Terazosin—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000222	0.000789	CcSEcCtD
Terazosin—Decreased appetite—Dexamethasone—ulcerative colitis	0.000222	0.000789	CcSEcCtD
Terazosin—Decreased appetite—Betamethasone—ulcerative colitis	0.000222	0.000789	CcSEcCtD
Terazosin—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.00022	0.000783	CcSEcCtD
Terazosin—Fatigue—Betamethasone—ulcerative colitis	0.00022	0.000783	CcSEcCtD
Terazosin—Fatigue—Dexamethasone—ulcerative colitis	0.00022	0.000783	CcSEcCtD
Terazosin—Shock—Prednisone—ulcerative colitis	0.000218	0.000778	CcSEcCtD
Terazosin—Pain—Betamethasone—ulcerative colitis	0.000218	0.000776	CcSEcCtD
Terazosin—Pain—Dexamethasone—ulcerative colitis	0.000218	0.000776	CcSEcCtD
Terazosin—Tachycardia—Prednisone—ulcerative colitis	0.000217	0.000772	CcSEcCtD
Terazosin—Hyperhidrosis—Prednisone—ulcerative colitis	0.000215	0.000764	CcSEcCtD
Terazosin—Asthenia—Hydrocortisone—ulcerative colitis	0.000214	0.000762	CcSEcCtD
Terazosin—Anorexia—Prednisone—ulcerative colitis	0.000212	0.000754	CcSEcCtD
Terazosin—Pruritus—Hydrocortisone—ulcerative colitis	0.000211	0.000752	CcSEcCtD
Terazosin—Feeling abnormal—Dexamethasone—ulcerative colitis	0.00021	0.000748	CcSEcCtD
Terazosin—Feeling abnormal—Betamethasone—ulcerative colitis	0.00021	0.000748	CcSEcCtD
Terazosin—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000208	0.000742	CcSEcCtD
Terazosin—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000208	0.000742	CcSEcCtD
Terazosin—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000207	0.000737	CcSEcCtD
Terazosin—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000207	0.000736	CcSEcCtD
Terazosin—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000204	0.000727	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000202	0.00072	CcSEcCtD
Terazosin—Dizziness—Prednisolone—ulcerative colitis	0.000202	0.00072	CcSEcCtD
Terazosin—Asthenia—Triamcinolone—ulcerative colitis	0.000202	0.000718	CcSEcCtD
Terazosin—Body temperature increased—Dexamethasone—ulcerative colitis	0.000202	0.000718	CcSEcCtD
Terazosin—Abdominal pain—Dexamethasone—ulcerative colitis	0.000202	0.000718	CcSEcCtD
Terazosin—Abdominal pain—Betamethasone—ulcerative colitis	0.000202	0.000718	CcSEcCtD
Terazosin—Body temperature increased—Betamethasone—ulcerative colitis	0.000202	0.000718	CcSEcCtD
Terazosin—Asthenia—Methylprednisolone—ulcerative colitis	0.000201	0.000716	CcSEcCtD
Terazosin—Insomnia—Prednisone—ulcerative colitis	0.000201	0.000715	CcSEcCtD
Terazosin—Paraesthesia—Prednisone—ulcerative colitis	0.000199	0.00071	CcSEcCtD
Terazosin—Pruritus—Triamcinolone—ulcerative colitis	0.000199	0.000708	CcSEcCtD
Terazosin—Pruritus—Methylprednisolone—ulcerative colitis	0.000198	0.000706	CcSEcCtD
Terazosin—Dizziness—Hydrocortisone—ulcerative colitis	0.000197	0.000703	CcSEcCtD
Terazosin—Dyspepsia—Prednisone—ulcerative colitis	0.000195	0.000696	CcSEcCtD
Terazosin—Decreased appetite—Prednisone—ulcerative colitis	0.000193	0.000687	CcSEcCtD
Terazosin—Rash—Prednisolone—ulcerative colitis	0.000193	0.000686	CcSEcCtD
Terazosin—Dermatitis—Prednisolone—ulcerative colitis	0.000192	0.000685	CcSEcCtD
Terazosin—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000192	0.000683	CcSEcCtD
Terazosin—Fatigue—Prednisone—ulcerative colitis	0.000191	0.000682	CcSEcCtD
Terazosin—Headache—Prednisolone—ulcerative colitis	0.000191	0.000682	CcSEcCtD
Terazosin—Constipation—Prednisone—ulcerative colitis	0.00019	0.000676	CcSEcCtD
Terazosin—Vomiting—Hydrocortisone—ulcerative colitis	0.00019	0.000676	CcSEcCtD
Terazosin—Rash—Hydrocortisone—ulcerative colitis	0.000188	0.00067	CcSEcCtD
Terazosin—Dermatitis—Hydrocortisone—ulcerative colitis	0.000188	0.000669	CcSEcCtD
Terazosin—Headache—Hydrocortisone—ulcerative colitis	0.000187	0.000666	CcSEcCtD
Terazosin—Dizziness—Triamcinolone—ulcerative colitis	0.000186	0.000662	CcSEcCtD
Terazosin—Dizziness—Methylprednisolone—ulcerative colitis	0.000185	0.00066	CcSEcCtD
Terazosin—Feeling abnormal—Prednisone—ulcerative colitis	0.000183	0.000652	CcSEcCtD
Terazosin—Asthenia—Betamethasone—ulcerative colitis	0.000183	0.000651	CcSEcCtD
Terazosin—Asthenia—Dexamethasone—ulcerative colitis	0.000183	0.000651	CcSEcCtD
Terazosin—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000182	0.000647	CcSEcCtD
Terazosin—Nausea—Prednisolone—ulcerative colitis	0.000181	0.000646	CcSEcCtD
Terazosin—Pruritus—Dexamethasone—ulcerative colitis	0.00018	0.000642	CcSEcCtD
Terazosin—Pruritus—Betamethasone—ulcerative colitis	0.00018	0.000642	CcSEcCtD
Terazosin—Vomiting—Triamcinolone—ulcerative colitis	0.000179	0.000636	CcSEcCtD
Terazosin—Vomiting—Methylprednisolone—ulcerative colitis	0.000178	0.000635	CcSEcCtD
Terazosin—Nausea—Hydrocortisone—ulcerative colitis	0.000177	0.000631	CcSEcCtD
Terazosin—Rash—Triamcinolone—ulcerative colitis	0.000177	0.000631	CcSEcCtD
Terazosin—Dermatitis—Triamcinolone—ulcerative colitis	0.000177	0.00063	CcSEcCtD
Terazosin—Rash—Methylprednisolone—ulcerative colitis	0.000177	0.00063	CcSEcCtD
Terazosin—Dermatitis—Methylprednisolone—ulcerative colitis	0.000177	0.000629	CcSEcCtD
Terazosin—Headache—Triamcinolone—ulcerative colitis	0.000176	0.000627	CcSEcCtD
Terazosin—Headache—Methylprednisolone—ulcerative colitis	0.000176	0.000625	CcSEcCtD
Terazosin—Abdominal pain—Prednisone—ulcerative colitis	0.000175	0.000625	CcSEcCtD
Terazosin—Body temperature increased—Prednisone—ulcerative colitis	0.000175	0.000625	CcSEcCtD
Terazosin—Diarrhoea—Betamethasone—ulcerative colitis	0.000174	0.000621	CcSEcCtD
Terazosin—Diarrhoea—Dexamethasone—ulcerative colitis	0.000174	0.000621	CcSEcCtD
Terazosin—Dizziness—Betamethasone—ulcerative colitis	0.000169	0.0006	CcSEcCtD
Terazosin—Dizziness—Dexamethasone—ulcerative colitis	0.000169	0.0006	CcSEcCtD
Terazosin—Nausea—Triamcinolone—ulcerative colitis	0.000167	0.000594	CcSEcCtD
Terazosin—Nausea—Methylprednisolone—ulcerative colitis	0.000167	0.000593	CcSEcCtD
Terazosin—Hypersensitivity—Prednisone—ulcerative colitis	0.000164	0.000583	CcSEcCtD
Terazosin—Vomiting—Betamethasone—ulcerative colitis	0.000162	0.000577	CcSEcCtD
Terazosin—Vomiting—Dexamethasone—ulcerative colitis	0.000162	0.000577	CcSEcCtD
Terazosin—Rash—Betamethasone—ulcerative colitis	0.000161	0.000572	CcSEcCtD
Terazosin—Rash—Dexamethasone—ulcerative colitis	0.000161	0.000572	CcSEcCtD
Terazosin—Dermatitis—Betamethasone—ulcerative colitis	0.000161	0.000572	CcSEcCtD
Terazosin—Dermatitis—Dexamethasone—ulcerative colitis	0.000161	0.000572	CcSEcCtD
Terazosin—Headache—Betamethasone—ulcerative colitis	0.00016	0.000569	CcSEcCtD
Terazosin—Headache—Dexamethasone—ulcerative colitis	0.00016	0.000569	CcSEcCtD
Terazosin—Asthenia—Prednisone—ulcerative colitis	0.000159	0.000567	CcSEcCtD
Terazosin—Pruritus—Prednisone—ulcerative colitis	0.000157	0.000559	CcSEcCtD
Terazosin—Diarrhoea—Prednisone—ulcerative colitis	0.000152	0.000541	CcSEcCtD
Terazosin—Nausea—Betamethasone—ulcerative colitis	0.000151	0.000539	CcSEcCtD
Terazosin—Nausea—Dexamethasone—ulcerative colitis	0.000151	0.000539	CcSEcCtD
Terazosin—Dizziness—Prednisone—ulcerative colitis	0.000147	0.000523	CcSEcCtD
Terazosin—Vomiting—Prednisone—ulcerative colitis	0.000141	0.000503	CcSEcCtD
Terazosin—Rash—Prednisone—ulcerative colitis	0.00014	0.000499	CcSEcCtD
Terazosin—Dermatitis—Prednisone—ulcerative colitis	0.00014	0.000498	CcSEcCtD
Terazosin—Headache—Prednisone—ulcerative colitis	0.000139	0.000495	CcSEcCtD
Terazosin—Nausea—Prednisone—ulcerative colitis	0.000132	0.00047	CcSEcCtD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	9.15e-05	0.0038	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	8.95e-05	0.00372	CbGpPWpGaD
Terazosin—ADRA1B—LPA receptor mediated events—CXCL8—ulcerative colitis	8.79e-05	0.00365	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	8.78e-05	0.00365	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—TP53—ulcerative colitis	8.54e-05	0.00355	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	8.45e-05	0.00351	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—CCL20—ulcerative colitis	8.39e-05	0.00349	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	8.34e-05	0.00347	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—GHRL—ulcerative colitis	8.29e-05	0.00344	CbGpPWpGaD
Terazosin—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	8.22e-05	0.00342	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	8.15e-05	0.00339	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	8.13e-05	0.00338	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	8.12e-05	0.00338	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—ADCY5—ulcerative colitis	7.97e-05	0.00331	CbGpPWpGaD
Terazosin—ADRA1B—LPA receptor mediated events—MMP9—ulcerative colitis	7.95e-05	0.00331	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	7.95e-05	0.0033	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CXCR1—ulcerative colitis	7.93e-05	0.0033	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	7.88e-05	0.00327	CbGpPWpGaD
Terazosin—ADRA1B—LPA receptor mediated events—NFKB1—ulcerative colitis	7.87e-05	0.00327	CbGpPWpGaD
Terazosin—ADRA1B—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	7.86e-05	0.00327	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—IL6—ulcerative colitis	7.82e-05	0.00325	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IL10—ulcerative colitis	7.75e-05	0.00322	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	7.66e-05	0.00318	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—CXCR2—ulcerative colitis	7.48e-05	0.00311	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	7.44e-05	0.00309	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	7.41e-05	0.00308	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	7.41e-05	0.00308	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	7.24e-05	0.00301	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	7.22e-05	0.003	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	7.19e-05	0.00299	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CXCR1—ulcerative colitis	7.05e-05	0.00293	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—CCR6—ulcerative colitis	7.03e-05	0.00292	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	7e-05	0.00291	CbGpPWpGaD
Terazosin—ADRA1A—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	6.98e-05	0.0029	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CCL20—ulcerative colitis	6.96e-05	0.00289	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	6.92e-05	0.00288	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	6.81e-05	0.00283	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	6.75e-05	0.0028	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	6.46e-05	0.00268	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	6.32e-05	0.00262	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	6.24e-05	0.00259	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CXCR2—ulcerative colitis	6.21e-05	0.00258	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—PTGER4—ulcerative colitis	6.19e-05	0.00257	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CCL20—ulcerative colitis	6.19e-05	0.00257	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	6.18e-05	0.00257	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	6.16e-05	0.00256	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	5.99e-05	0.00249	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	5.97e-05	0.00248	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CCR6—ulcerative colitis	5.84e-05	0.00243	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—GHRL—ulcerative colitis	5.67e-05	0.00236	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CXCR2—ulcerative colitis	5.51e-05	0.00229	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	5.49e-05	0.00228	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CXCR1—ulcerative colitis	5.4e-05	0.00224	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	5.3e-05	0.0022	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CCR6—ulcerative colitis	5.18e-05	0.00215	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—PTGER4—ulcerative colitis	5.14e-05	0.00214	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	5.11e-05	0.00213	CbGpPWpGaD
Terazosin—ADRA1B—AMPK Signaling—TP53—ulcerative colitis	5.08e-05	0.00211	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—TNF—ulcerative colitis	5.02e-05	0.00209	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CXCR1—ulcerative colitis	4.9e-05	0.00204	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CCL20—ulcerative colitis	4.74e-05	0.00197	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—GHRL—ulcerative colitis	4.7e-05	0.00195	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—ADRB2—ulcerative colitis	4.69e-05	0.00195	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—PTGER4—ulcerative colitis	4.56e-05	0.0019	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	4.56e-05	0.0019	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	4.54e-05	0.00189	CbGpPWpGaD
Terazosin—ADRA1A—AMPK Signaling—TP53—ulcerative colitis	4.51e-05	0.00188	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCR1—ulcerative colitis	4.48e-05	0.00186	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—GNA12—ulcerative colitis	4.46e-05	0.00185	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	4.4e-05	0.00183	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	4.37e-05	0.00181	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	4.37e-05	0.00181	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCL20—ulcerative colitis	4.31e-05	0.00179	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	4.24e-05	0.00176	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CXCR2—ulcerative colitis	4.23e-05	0.00176	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—GHRL—ulcerative colitis	4.18e-05	0.00174	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCR1—ulcerative colitis	4.07e-05	0.00169	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	4.07e-05	0.00169	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—IL6—ulcerative colitis	4.05e-05	0.00168	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IL2—ulcerative colitis	4.05e-05	0.00168	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—GNA12—ulcerative colitis	4.05e-05	0.00168	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCR1—ulcerative colitis	3.98e-05	0.00165	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CCR6—ulcerative colitis	3.97e-05	0.00165	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CCL20—ulcerative colitis	3.94e-05	0.00164	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—ADRB2—ulcerative colitis	3.89e-05	0.00162	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CXCR2—ulcerative colitis	3.84e-05	0.00159	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—GNA12—ulcerative colitis	3.7e-05	0.00154	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	3.65e-05	0.00152	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCR1—ulcerative colitis	3.62e-05	0.0015	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCR6—ulcerative colitis	3.61e-05	0.0015	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCL20—ulcerative colitis	3.57e-05	0.00149	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SEL1L—ulcerative colitis	3.52e-05	0.00146	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCR2—ulcerative colitis	3.51e-05	0.00146	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PTGER4—ulcerative colitis	3.5e-05	0.00145	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CCL20—ulcerative colitis	3.5e-05	0.00145	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—ADRB2—ulcerative colitis	3.46e-05	0.00144	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—GNA12—ulcerative colitis	3.36e-05	0.0014	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CCR6—ulcerative colitis	3.3e-05	0.00137	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—GNA12—ulcerative colitis	3.29e-05	0.00137	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	3.25e-05	0.00135	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—GHRL—ulcerative colitis	3.2e-05	0.00133	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCR2—ulcerative colitis	3.19e-05	0.00132	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PTGER4—ulcerative colitis	3.18e-05	0.00132	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCL20—ulcerative colitis	3.17e-05	0.00132	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	3.16e-05	0.00131	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCR2—ulcerative colitis	3.12e-05	0.00129	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCR6—ulcerative colitis	2.99e-05	0.00124	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—GNA12—ulcerative colitis	2.98e-05	0.00124	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.98e-05	0.00124	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—TNF—ulcerative colitis	2.95e-05	0.00123	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CCR6—ulcerative colitis	2.93e-05	0.00122	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SEL1L—ulcerative colitis	2.92e-05	0.00121	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—GHRL—ulcerative colitis	2.91e-05	0.00121	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PTGER4—ulcerative colitis	2.9e-05	0.00121	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCR1—ulcerative colitis	2.9e-05	0.0012	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCR2—ulcerative colitis	2.83e-05	0.00118	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CALM3—ulcerative colitis	2.82e-05	0.00117	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.72e-05	0.00113	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCR6—ulcerative colitis	2.66e-05	0.00111	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—GHRL—ulcerative colitis	2.66e-05	0.0011	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—ADRB2—ulcerative colitis	2.65e-05	0.0011	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PTGER4—ulcerative colitis	2.64e-05	0.0011	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SEL1L—ulcerative colitis	2.59e-05	0.00108	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PTGER4—ulcerative colitis	2.58e-05	0.00107	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCL20—ulcerative colitis	2.54e-05	0.00106	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CHP1—ulcerative colitis	2.51e-05	0.00104	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.47e-05	0.00103	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—GHRL—ulcerative colitis	2.41e-05	0.001	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—ADRB2—ulcerative colitis	2.41e-05	0.001	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCR1—ulcerative colitis	2.4e-05	0.000999	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GNA12—ulcerative colitis	2.39e-05	0.000994	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—GHRL—ulcerative colitis	2.36e-05	0.000981	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PTGER4—ulcerative colitis	2.34e-05	0.000973	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CALM3—ulcerative colitis	2.34e-05	0.000972	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCR2—ulcerative colitis	2.27e-05	0.000942	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—CXCL8—ulcerative colitis	2.27e-05	0.000942	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	2.26e-05	0.000938	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—ADCY5—ulcerative colitis	2.25e-05	0.000935	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—ADRB2—ulcerative colitis	2.2e-05	0.000914	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.19e-05	0.000912	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—DLD—ulcerative colitis	2.17e-05	0.0009	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.16e-05	0.000897	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—GHRL—ulcerative colitis	2.14e-05	0.000891	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCR1—ulcerative colitis	2.14e-05	0.000888	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCR6—ulcerative colitis	2.13e-05	0.000886	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL20—ulcerative colitis	2.11e-05	0.000877	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CALM3—ulcerative colitis	2.08e-05	0.000863	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—ADCY5—ulcerative colitis	2.04e-05	0.000849	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAML2—ulcerative colitis	2.02e-05	0.00084	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—ADRB2—ulcerative colitis	2e-05	0.00083	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GNA12—ulcerative colitis	1.98e-05	0.000825	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—ADRB2—ulcerative colitis	1.95e-05	0.000812	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCR2—ulcerative colitis	1.88e-05	0.000782	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CXCL8—ulcerative colitis	1.88e-05	0.000782	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTGER4—ulcerative colitis	1.88e-05	0.00078	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL20—ulcerative colitis	1.88e-05	0.000779	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.87e-05	0.000779	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.87e-05	0.000778	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—ADCY5—ulcerative colitis	1.87e-05	0.000776	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—ADRB2—ulcerative colitis	1.77e-05	0.000738	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCR6—ulcerative colitis	1.77e-05	0.000735	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GNA12—ulcerative colitis	1.76e-05	0.000733	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GHRL—ulcerative colitis	1.72e-05	0.000714	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—ADCY5—ulcerative colitis	1.7e-05	0.000705	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAML2—ulcerative colitis	1.68e-05	0.000697	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCR2—ulcerative colitis	1.67e-05	0.000695	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CXCL8—ulcerative colitis	1.67e-05	0.000694	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CALM3—ulcerative colitis	1.66e-05	0.000692	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.66e-05	0.000692	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—ADCY5—ulcerative colitis	1.66e-05	0.000689	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RIPK2—ulcerative colitis	1.64e-05	0.000681	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCR6—ulcerative colitis	1.57e-05	0.000653	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.56e-05	0.000648	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTGER4—ulcerative colitis	1.56e-05	0.000647	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—ADCY5—ulcerative colitis	1.51e-05	0.000626	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAML2—ulcerative colitis	1.49e-05	0.000619	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.46e-05	0.000607	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.46e-05	0.000605	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GHRL—ulcerative colitis	1.43e-05	0.000593	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADRB2—ulcerative colitis	1.42e-05	0.000591	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—JAK2—ulcerative colitis	1.4e-05	0.000583	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTGER4—ulcerative colitis	1.38e-05	0.000575	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CALM3—ulcerative colitis	1.38e-05	0.000574	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RIPK2—ulcerative colitis	1.36e-05	0.000565	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.28e-05	0.000534	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CXCL8—ulcerative colitis	1.28e-05	0.000532	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—JAK2—ulcerative colitis	1.27e-05	0.000529	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GHRL—ulcerative colitis	1.27e-05	0.000526	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CALM3—ulcerative colitis	1.23e-05	0.00051	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—IL2—ulcerative colitis	1.22e-05	0.000509	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RIPK2—ulcerative colitis	1.21e-05	0.000502	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADCY5—ulcerative colitis	1.21e-05	0.000502	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADRB2—ulcerative colitis	1.18e-05	0.000491	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—JAK2—ulcerative colitis	1.16e-05	0.000484	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CXCL8—ulcerative colitis	1.16e-05	0.000483	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL2—ulcerative colitis	1.11e-05	0.000462	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCL8—ulcerative colitis	1.06e-05	0.000442	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—JAK2—ulcerative colitis	1.06e-05	0.000439	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	1.05e-05	0.000436	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.05e-05	0.000435	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	1.03e-05	0.00043	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—IL2—ulcerative colitis	1.02e-05	0.000422	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADCY5—ulcerative colitis	1e-05	0.000416	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	9.79e-06	0.000407	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCL8—ulcerative colitis	9.65e-06	0.000401	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	9.44e-06	0.000392	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CALM3—ulcerative colitis	9.43e-06	0.000392	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	9.39e-06	0.00039	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL2—ulcerative colitis	9.22e-06	0.000383	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	9.02e-06	0.000375	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	8.9e-06	0.00037	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	8.57e-06	0.000356	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	8.19e-06	0.00034	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—JAK2—ulcerative colitis	7.53e-06	0.000313	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RELA—ulcerative colitis	7.29e-06	0.000303	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCL8—ulcerative colitis	6.87e-06	0.000285	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ADCY5—ulcerative colitis	6.84e-06	0.000284	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL2—ulcerative colitis	6.56e-06	0.000273	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6—ulcerative colitis	6.53e-06	0.000271	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—JAK2—ulcerative colitis	6.25e-06	0.00026	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MMP9—ulcerative colitis	6.21e-06	0.000258	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NFKB1—ulcerative colitis	6.15e-06	0.000255	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RELA—ulcerative colitis	6.05e-06	0.000251	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL8—ulcerative colitis	5.7e-06	0.000237	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	5.55e-06	0.000231	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—STAT3—ulcerative colitis	5.52e-06	0.00023	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL2—ulcerative colitis	5.45e-06	0.000226	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6—ulcerative colitis	5.42e-06	0.000225	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	5.37e-06	0.000223	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP9—ulcerative colitis	5.16e-06	0.000214	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TGFB1—ulcerative colitis	5.12e-06	0.000213	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NFKB1—ulcerative colitis	5.1e-06	0.000212	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARG—ulcerative colitis	5.1e-06	0.000212	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	5.06e-06	0.00021	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	4.84e-06	0.000201	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	4.82e-06	0.0002	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALB—ulcerative colitis	4.59e-06	0.000191	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—STAT3—ulcerative colitis	4.58e-06	0.000191	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	4.58e-06	0.00019	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	4.53e-06	0.000188	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TGFB1—ulcerative colitis	4.25e-06	0.000177	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TP53—ulcerative colitis	4.22e-06	0.000175	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	4.07e-06	0.000169	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS2—ulcerative colitis	4.01e-06	0.000167	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6—ulcerative colitis	3.86e-06	0.00016	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	3.78e-06	0.000157	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TP53—ulcerative colitis	3.5e-06	0.000145	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6—ulcerative colitis	3.2e-06	0.000133	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	3.11e-06	0.000129	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	2.84e-06	0.000118	CbGpPWpGaD
